WW 16 (Glycopyrrolate 2 mg)
Pill imprint WW 16 has been identified as Glycopyrrolate 2 mg.
Glycopyrrolate is used in the treatment of anesthesia; excessive salivation; peptic ulcer; copd, maintenance and belongs to the drug class anticholinergics/antispasmodics. There is no proven risk in humans during pregnancy. Glycopyrrolate 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WW 16
- 2 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- West-Ward Pharmaceutical Corporation
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
More about glycopyrrolate
- Glycopyrrolate solution
- Glycopyrrolate tablets
- Glycopyrrolate inhalation
- Glycopyrrolate (Advanced Reading)
- Glycopyrrolate Inhalation (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.